Detect Early, Treat Effectively
Early detection of gastric cancer through comprehensive assessment improves treatment options and outcomes, ensuring timely and effective medical care.

GLP1 for NAFLD and Metabolic Syndrome
Prevention Starts with a

What is GLP1?
GLP1 (Glucagon-Like Peptide 1) is a hormone that helps regulate blood sugar levels by enhancing insulin secretion, inhibiting glucagon release, and slowing gastric emptying.
When GLP1 Treatment for NAFLD and Metabolic Syndrome Becomes Necessary
Ongoing symptoms may indicate an underlying condition. Consider seeing a gastro specialist if you're experiencing some of these symptoms
GLP1 treatment for NAFLD and metabolic syndrome is recommended if you have:
Elevated Liver Enzymes
Type 2 Diabetes
Fatty Liver on Imaging
Insulin Resistance
Metabolic Risk Factors Like Obesity

How Does GLP1 Work?
GLP1 treatment for NAFLD and metabolic syndrome involves regular injections of GLP1 receptor agonists. It helps manage NAFLD and metabolic syndrome by enhancing insulin secretion, reducing glucagon release, slowing gastric emptying, and promoting satiety, which aids in weight loss and improves liver function.
What Happens During Your Procedure?
Meet Your Endoscopy & Gastrointestinal Specialists
Dr. John Hsiang
Senior Consultant Gastroenterologist
MBChB(NZ), FRACP(Australasia), MD(Doctorate), FRCP(Edinburgh), FAMS(Gastro)
Dr. John Hsiang is a seasoned gastroenterologist and hepatologist with over two decades of clinical experience. His distinguished career includes training at Otago Medical School and the Prince of Wales Hospital in Hong Kong, specializing in liver disease and gastrointestinal disorders. Dr. Hsiang is dedicated to patient education, empowering individuals with the knowledge and confidence to manage their health.

Common Questions about GLP Treatment for NAFLD and Metabolic Syndrome
Conditions
Understanding the Causes and Finding Relief